Michael Douglas Taylor, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 30,000 shares at $64.67 ($1.9M) on 2020-11-04, disclosed to the SEC on 2020-11-06.
Open-market sale of $1.9M DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.67 | 12,169 | $787K | 40.5% |
| 2 | $64.67 | 12,169 | $787K | 40.5% |
| 3 | $65.36 | 2,831 | $185K | 9.5% |
| 4 | $65.36 | 2,831 | $185K | 9.5% |
| Total | $64.80 avg | 30,000 | $1.9M | 100% |
| Filing → |
| DCPH | SELL | 2021-03-03 | $655K | — | Filing → |
| DCPH | SELL | 2021-02-03 | $687K | — | Filing → |
| DCPH | SELL | 2021-01-06 | $2.1M | — | Filing → |